The synthesis and antiviral activity of an original series of 6-benzoyl-benzoxazolin-2-one and 6-benzoyl-benzothiazolin-2-one derivatives are described. Several compounds were found to have a selective inhibitory activity against human cytomegalovirus (HCMV) and varicella-zoster virus (VZV) in vitro, being inactive against a variety of other DNA and RNA viruses. 6-(3-fluorobenzoyl)benzoxazolin-2-one, 6-(3-fluorobenzoyl)benzothiazolin-2-one, 6-(3-bromobenzoyl)benzothiazolin-2-one, 6-(3-iodobenzoyl)benzothiazolin-2-one, 3-methyl-6-(3-fluorobenzoyl)benzothiazolin-2-one, 3-benzyl-6-benzoyl-benzothiazolin-2-one, 3-benzyl-6-(3-fluorobenzoyl)benzothiazolin-2-one and 3-benzoyl-6-(3-fluorobenzoyl)benzothiazolin-2-one were the most active of the series against HCMV and VZV with a selectivity index (CC50/IC50) ranging from 10 to 20. They displayed similar activity against thymidine kinase competent (TK+) and deficient (TK−) VZV strains, and also proved to be active against clinical HCMV isolates that were resistant to ganciclovir (GCV). Time-of-addition experiments revealed a site of interaction with the HCMV replicative cycle that may be close or similar to that of GCV and cidofovir (HPMPC). The compounds showed poor, if any, activity against herpes simplex virus type 1 (HSV-1) and HSV-2, and were not inhibitory against human immunodeficiency virus and other DNA and RNA viruses. Therefore, these compounds may represent a novel lead for the development of specific HCMV and VZV drugs.
AichaouiHPoupaertJHLesieurD & HénichartJ-P (1991) Regioselectivity in the C-acylation of 2(3H)-benzoxazolones. Tetrahedron47: 6649–6654.
2.
AlfordCA & BrittWJ (1993) Cytomegalovirus. In The Human Herpesviruses, pp. 227–255. Edited by RoizmanBWhitleyRJ & LopezCNew York: Raven Press.
3.
AlfordCAStagnoSPassRF & BrittWJ (1990) Congenital and perinatal cytomegalovirus infections. Reviews of Infectious Diseases12: S745–S753.
4.
Anonymous (1978) Anticonvulsivant Screening Project. Antiepileptic Drug Development Program, National Institutes of Health. DHEW (NIH) Publication; NIH 78–1093.
5.
BalzariniJNaesensLSlachmuyldersJNiphuisHRosenbergIHolÿASchellekensH & De ClercqE (1991) 9-(2-Phosphonylmethoxyethyl)adenine (PMEA) effectively inhibits simian immunodeficiency virus (SIV) infection in Rhesus monkeys. AIDS5: 21–28.
6.
BonteJPLesieurDLespagnolCPlatM & CazinM (1974) 6-Acyl-benzoxazolinones. European Journal of Medicinal Chemistry9: 491–496.
7.
CassadyKA & WhitleyRJ (1997) New therapeutic approaches to the alphaherpesvirus infections. Journal of Antimicrobial Chemotherapy39: 119–128.
8.
ChrispP & ClissoldSP (1991) Foscarnet: A review of its antiviral activity, pharmacokinetic properties and therapeutic use in immunocompromised patients with cytomegalovirus retinitis. Drugs41: 104–129.
9.
De ClercqEDescampsJVerhelstGWalkerRTJonesASTorrencePF & ShugarD (1980) Comparative efficacy of antiherpes drugs against different strains of herpes simplex virus. Journal of Infectious Diseases141: 563–574.
10.
De ClercqEHolÿARosenbergISakumaTBalzariniJ & MaudgalPC (1986) A novel selective broad-spectrum anti-DNA virus agent. Nature323: 464–467.
11.
FieldAK & BironKK (1994) ‘The end of innocence’ revisited: Resistance of herpesviruses to antiviral drugs. Clinical Microbiology Reviews7: 1–13.
12.
GallantJEMooreRDRichmanDDKerulyJ & ChaissonRE (1992) Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with zidovudine. Journal of Infectious Diseases166: 1223–1227.
13.
GroenvickME (1876) Sur l'action de l'éther chloroxycarbonique sur l'amidophénol. Bulletin de la Societe Chimique de Paris25: 177–180.
14.
KolasaK & KleinrokZ (1979) Central effects of new acyl and aminomethyl derivatives of benzoxazol-2-one. Acta Poloniae Pharmaceuticae36: 383–391.
15.
KrallRLPenryJKWhiteBJKupferbergHJ & SwinyardEA (1978) Antiepileptic drug development II. Anticonvulsant drug screening. Epilepsia19: 409–428.
16.
MoussaviZPlanckeMOOlivierPLesieurDFruchartJC & SauzieresJ (1989) Lipid lowering actions of 7-(2-methylene butyryl)-(2H)-1,4-benzoxazin-3-(4H)-one derivatives in mice, rats and Syrian hamsters. Clinica Chimica Acta180: 35–44.
17.
OrcuttJAPrytherchJBKonikovM & MichaelsonSM (1964) Some new compounds exhibiting selective central nerve depressant activities. I. Preliminary observations. Archives Internationales de Pharmacodynamie et de Therapie152: 121–131.
18.
PaskovDBakurdshievAKalchevaVSimovDKamenovaL & BoichevaKH (1975) Pharmacological activity of benzoxazolinones. Farmatsiya25: 61–74.
19.
PorterRJCerighinoHJScovilleB & WhiteBG (1984) Antiepileptic drug development program. Cleveland Clinic Quarterly51: 293–305.
20.
RoartyJDFisherEJ & NussbaumJJ (1993) Long-term visual morbidity of cytomegalovirus retinitis in patients with acquired immune deficiency syndrome. Ophthalmology100: 1685–1688.
21.
RubinRH (1990) Impact of cytomegalovirus infection on organ transplant recipients. Reviews of Infectious Diseases12: S754–S766.
22.
SandersEHGardnerPDBergerPJ & NegusNC (1981) 6-methoxybenzoxazolinone: A plant derivative that stimulates reproduction in Microtus montanus. Science214: 67–69.
23.
SnoeckRAndreiG & De ClercqE (1994) Chemotherapy of varicella zoster virus infections. International Journal of Antimicrobial Agents4: 211–226.
24.
TacquetALespagnolCBeerensHLesieurD & DevulderB (1971) Antimicrobial activity of derivatives of benzoxazolinone. Annales de l'Institut Pasteur de Lille22: 189–200.
25.
TurkCFKrapchoJMichelIM & WeinrybI (1977) Synthesis and central nervous system of 2-arylidene-4-aminoalkyl-2H-1,4-benzoxazin-3(4H)-ones and related compounds. Journal of Medicinal Chemistry20: 729–732.
26.
UcarHVan derpoortenKKanyonyoMIsaMLambertDLesieurD & PoupaertJH (1996) Synthesis of 6-acyl-2(3H)-benzoxazolones and 6-acyl-2(3H)-benzothiazolones. Bulletin des Societes Chimiques Belges105: 773–776.
27.
UcarHCacciaguerraSSpampinatoSVan derpoortenKIsaMKanyonyoM & PoupaertJH (1997a) 2(3H)-benzoxazolone and 2(3H)-benzothiazolone derivatives: Novel, potent and selective σ1 receptor ligands. European Journal of Pharmacology335: 267–273.
28.
UcarHVan derpoortenK & PoupaertJH (1997b) AlCl3-DMF reagent in the Friedel-Crafts reaction. Application to the synthesis of symmetrical benzophenone derivatives. Heterocycles45: 805–810.
29.
UcarHVan derpoortenKSpampinatoSCacciaguerraSDepoverePStablesJPIsaMMasereelBDelargeJ & PoupaertJH (1998a) Synthesis and anticonvulsant activity of 2(3H)-benzoxazolone and 2(3H)-benzothiazolone derivatives. Journal of Medicinal Chemistry41: 1138–1145.
30.
UcarHVan derpoortenKDepoverePLesieurDIsaMMasereelBDelargeJ & PoupaertJH (1998b) ‘Fries-like’ rearrangement: A novel and efficient method for the synthesis of 6-acyl-2(3H)-benzoxazolones and 6-acyl-2(3H)-benzothiazolones. Tetrahedron54: 1763–1772.
31.
WestCTDonnellySJKooistraDA & DoyleMP (1973) Silane reduction in acidic media. II. Reductions of aryl aldehydes and ketones by trialkylsilanes in trifluoroacetic acid. A selective method for converting the carbonyl group to methylene. Journal of Organic Chemistry38: 2675–2681.
32.
WingardJRPiantadosiSBurnsWHZahurakMLSantosGW & SaralR (1990) Cytomegalovirus infections in bone marrow transplant recipients given intensive cytoreductive therapy. Reviews of Infectious Diseases12: S793–S804.
33.
YousSPoupaertJHLesieurIDepreuxP & LesieurD (1994) AlCl3-DMF reagent in the Friedel-Crafts reaction. Application to the acylation reaction of 2(3H)-benzothiazolones. Journal of Organic Chemistry59: 1574–1576.
